Hospira Carboplatin I.V. Infusion 50mg/5mL single dose vial

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

carboplatin, Quantity: 10 mg/mL

Disponibbli minn:

Hospira Australia Pty Ltd

INN (Isem Internazzjonali):

Carboplatin

Għamla farmaċewtika:

Injection, intravenous infusion

Kompożizzjoni:

Excipient Ingredients: water for injections

Rotta amministrattiva:

Intravenous Infusion

Unitajiet fil-pakkett:

1 X 5 mL

Klassi:

Medicine Listed (Export Only)

Tip ta 'preskrizzjoni:

(S1) This Schedule is intentionally blank

Indikazzjonijiet terapewtiċi:

Head and neck cancer, small cell lung cancer, testicular cancer, ovarian cancer, uterine cancer, malignant lymphoma, non-small cell lung cancer, breast cancer Used in conjunction with other antineoplastic drugs for the following malignant tumours: Paediatric solid malignant tumours (neuroblastoma/retinoblastoma/ hepatoblastoma/central nervous system neuroblastoma, recurrent or refractory Ewing?s sarcoma family tumours/nephroblastoma)

Sommarju tal-prodott:

Visual Identification: Carboplatin Injection is a clear, colourless or pale yellow liquid.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2013-10-09